Cassava Sciences, Inc. at the Biomarkers for Alzheimer’s Disease Summit

Jul 15, 2020
9:10 AM EDT

Title: Early Clinical Results with SavaDx, an Investigational Blood-based Diagnostic/Biomarker for Alzheimer’s Disease

Supporting Materials